Abstract:Objective Elevated double-stranded DNA (dsDNA) antibody levels in blood serum are considered a disease-specific marker in systemic lupus erythematosus (SLE), correlate with disease activity and the incidence of lupus nephritis, and can be detected in up to 86% of all SLE cases. Despite the high clinical relevance, the variety of dsDNA antibody testing methods with heterogenous performance in clinical use remains challenging. This study is the first to prospectively investigate the performance of two of today’s most commonly applied anti-dsDNA testing methods head-to-head under real-world conditions, as well as their correlation with other clinical and serological disease parameters in SLE patients. Methods In this prospective study, all SLE patients undergoing treatment at the Department of Rheumatology at the University Hospital Bonn within a 13-months period (n=41) and control patients without connective-tissue disease (n=51) were consecutively enrolled and examined. For all study participants’ serum samples both anti-dsDNA-NcX enzyme-linked immunoassay testing EUROIMMUN, Luebeck, Germany) and the fluorescence immunoassay ELiA dsDNA (Thermo Fisher Scientific, Waltham, USA) were performed. In addition, demographic data, further laboratory values and disease activity parameters were recorded. Clinical disease activity was assessed by SLEDAI-2K. Results Both assays showed high specificity (anti-dsDNA-NcX ELISA: 0.9, ELiA dsDNA: 0.959), but there were notable differences in sensitivity (anti-dsDNA-NcX ELISA: 0.51, ELiA dsDNA: 0.38). Pearsons’s correlation yielded a positive correlation between anti-dsDNA concentrations and CRP concentrations for the anti-dsDNA-NcX ELISA (R=0.22; p=0.038) and a mild-to-moderate inverse correlation between concentrations of anti-dsDNA and complement C4 for the ELiA dsDNA test (R=-0.22; p=0.045) when SLE and control patients were considered together. Other than, no significant correlation between anti-dsDNA concentrations and clinical or laboratory findings was found for either test procedure. Conclusion Both anti-dsDNA antibody assays represent reliable examination methods with high specificity for the diagnosis of SLE that fulfill EULAR/ACR requirements. However, the anti-dsDNA-NcX ELISA showed superior sensitivity and significant correlation with disease activity (as measured by CRP concentrations).

Clinical significance of combined detection of autoantibodies in patients with systemic lupus erythematosus

Significance of combined detection of autoantibodies in systemic lupus erythematosus

[The Clinical Significance of Hematological Damage in Systemic Lupus Erythematosus and Related Antibodies].

Analysis of combined dectection of ANA,ENA and dsDNA in 173 Systemic Lupus Erythematosus patients

An assessment on diagnostic efficacy of different methods in combination for the detection of anti-dsDNA antibody in SLE patients

The clinical value of antinuclear antibody spectrum for diagnosing systemic lupus erythematosus

Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus.

Clinical utility of high avidity anti-dsDNA antibody in the diagnosis of systemic lupus erythematosus

Values of qualitative assays for anti-ds-DNA and anti-nucleosome antibodies in diagnosis of systemic lupus erythematosus

Association Analysis Etween Anti-nucleosome Antibodies: with Clinical Features and Disease Activity in Systemic Lupus Erythematosus of Chinese Han

Clinical Performance of Enzyme Linked Immunosorbent Assay Detecting Serum Antibodies Against Double-stranded DNA in Diagnosis of Systemic Lupus Erythematosus

Clinical Evaluation of A New Quantitative Enzyme-Linked Immunosorbent Assay for Anti-Dsdna Antibodies Measured in Patients with Systemic Lupus Erythematosus

The correlation between the avidity or level of serum anti-dsDNA antibody with SLE disease progression and their influence on the performance of different detection techniques

Role of Anti-Nucleosome Antibody in the Diagnosis of Systemic Lupus Erythematosus

Determination of specific autoantibodies in patients with systemic lupus erythematosus by Line immunoassay, ELISA and CLIF assay

The Performance of Different Anti-Dsdna Autoantibodies Assays in Chinese Systemic Lupus Erythematosus Patients

Association of urine autoantibodies with disease activity in systemic lupus erythematosus

Comparative analysis of contemporary anti-double stranded DNA antibody assays for systemic lupus erythematosus

Anticardiolipin antibodie in combination with AdsDNA, urine protein, complement C3 and CA for the clinical diagnose of systemic lupus erythematosus(SLE)

Two tests to detect anti-double stranded DNA antibodies in the diagnostic value of systemic lupus erythematosus